The GE2P2 Global Foundation – a 2016 spin-off from the Division of Medical Ethics, NYU School of Medicine – has launched a multi-year initiative to assess and materially strengthen informed consent in genomic medicine. The Foundation’s Center for Informed Consent Integrity is supporting this effort led by co-PIs Barbara Redman, PhD, MBE, a Senior Fellow of the Foundation, and David Curry, its President.